<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004942'>Aortic aneurysms</z:hpo> are an important cause of mortality in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>Monogenic disorders such as the <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) are good genetic models for the pathogenesis of <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, progressive <z:mpath ids='MPATH_66'>dilatation</z:mpath> of the aortic root leads to <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> and dissection, often associated with precocious <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Early pathogenetic models for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> focused upon structural <z:mp ids='MP_0000746'>weakness</z:mp> of the tissues imposed by microfibrillar deficiency </plain></SENT>
<SENT sid="4" pm="."><plain>However, recent studies of transgenic mouse models have challenged this model and demonstrated a central role for the upregulation of the TGFbeta signaling pathway </plain></SENT>
<SENT sid="5" pm="."><plain>The discovery of a new <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> syndrome, the Loeys-Dietz syndrome (LDS), confirmed the importance of the cytokine TGFbeta in <z:hpo ids='HP_0002617'>aneurysm</z:hpo> pathogenesis </plain></SENT>
<SENT sid="6" pm="."><plain>The main distinguishing features between LDS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> include the presence of <z:hpo ids='HP_0000316'>hypertelorism</z:hpo>, <z:hpo ids='HP_0000175'>cleft palate</z:hpo>/<z:hpo ids='HP_0000193'>bifid uvula</z:hpo> and <z:hpo ids='HP_0005116'>arterial tortuosity</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>LDS is caused by mutations in the genes encoding the receptors for TGFbeta (TGFBR1/2) </plain></SENT>
<SENT sid="8" pm="."><plain>This insight helped to elucidate the pathogenesis of another rare <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e>, <z:hpo ids='HP_0005116'>arterial tortuosity</z:hpo> syndrome </plain></SENT>
<SENT sid="9" pm="."><plain>This disease is caused by mutations in the SLC2A10 gene, coding for GLUT10, a member of the <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter family </plain></SENT>
<SENT sid="10" pm="."><plain>In analogy to LDS, we demonstrated an upregulation of TGFbeta in ATS </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, <z:hpo ids='HP_0000001'>all</z:hpo> these insights have also lead to new therapeutic insights </plain></SENT>
<SENT sid="12" pm="."><plain>In transgenic mouse models it was shown that <z:chebi fb="0" ids="6541">losartan</z:chebi>, an <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor with known inhibiting effects on TGFbeta, rescues the aortic phenotype </plain></SENT>
<SENT sid="13" pm="."><plain>If these promising results are confirmed in human trials, <z:chebi fb="0" ids="6541">losartan</z:chebi> might have beneficial effects in the treatment of more common nonhereditary <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> </plain></SENT>
</text></document>